Compare SHOP & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHOP | ABT |
|---|---|---|
| Founded | 2004 | 1888 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.4B | 189.6B |
| IPO Year | 2015 | N/A |
| Metric | SHOP | ABT |
|---|---|---|
| Price | $111.33 | $110.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 32 | 18 |
| Target Price | ★ $167.48 | $141.00 |
| AVG Volume (30 Days) | 11.3M | ★ 13.4M |
| Earning Date | 02-11-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | ★ 28.16 | N/A |
| EPS | 1.36 | ★ 3.72 |
| Revenue | $10,696,000,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $31.82 | $8.92 |
| Revenue Next Year | $23.96 | $7.39 |
| P/E Ratio | $82.67 | ★ $29.79 |
| Revenue Growth | ★ 30.25 | 5.67 |
| 52 Week Low | $69.84 | $105.27 |
| 52 Week High | $182.19 | $141.23 |
| Indicator | SHOP | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 23.32 | N/A |
| Support Level | $108.79 | N/A |
| Resistance Level | $144.14 | N/A |
| Average True Range (ATR) | 6.46 | 0.00 |
| MACD | -3.11 | 0.00 |
| Stochastic Oscillator | 8.87 | 0.00 |
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.